
14.15 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 13.19 Today|||52-Week Range 17.15 | -9.33% Year-to-Date |
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? Nov 17 / Zacks.com - Paid Partner Content |
Previous close | 14.02 |
Today’s open | 14.09 |
Day’s range | 14.05 - 14.15 |
Volume | 1,965,276 |
Average volume (3 months) | 1,988,689 |
Market cap | $44.1B |
Earnings growth (last year) | +15.12% |
Earnings growth (this year) | -43.64% |
Earnings growth (next 5 years) | -3.00% |
Revenue growth (last year) | -6.43% |
P/E ratio | 34.5 |
Price/Sales | 1.74 |
Price/Book | 0.91 |
Next reporting date | February 1, 2024 |
EPS forecast (this quarter) | $0.16 |
Annual revenue (last year) | $29.7B |
Annual profit (last year) | $2.3B |
Net profit margin | 7.87% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |